Form 4 Filing for AVANOS MEDICAL, INC.

This filing details transactions by Scott Michael Galovan, SVP and Chief Financial Officer of AVANOS MEDICAL, INC. On March 13, 2026, Galovan acquired 29,481 shares of Common Stock under the Issuer's 2021 Long Term Incentive Plan, with a reported transaction price of $0.0. This acquisition vests in tranches through March 13, 2029. Additionally, an employee stock option (right to buy) for 69,630 shares of Common Stock was granted, with an exercise price of $13.69 and vesting schedule through March 13, 2029. Following these transactions, Galovan directly owns 139,824 shares of Common Stock and holds options for 96,212 shares.